Objective To describe the similarities and differences in the evaluation and treatment of
multisystem inflammatory syndrome in children (MIS-C) at hospitals in the US. Study design …

Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …

Objectives To synthesize the current data on clinico-laboratory features, intensive care
needs, treatment, and outcome of Pediatric inflammatory multisystem syndrome temporally …

Context: Multisystem inflammatory syndrome in children (MIS-C) is an emerging condition
after the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Background Multisystem inflammatory syndrome in children (MIS-C) is a severe
hyperinflammatory condition in persons aged< 21 years associated with antecedent severe …

Multisystem inflammatory syndrome in children (MIS-C) is a pediatric hyperinflammatory
syndrome related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Multisystem inflammatory syndrome in children (MIS-C) has been observed in temporal
association with coronavirus disease 2019 (COVID-19), typically within 2 to 6 weeks of …

This study was conducted to assess the clinical spectrum, management, and outcome of
SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C). We reviewed …

The acute manifestations and short-term outcomes of multisystem inflammatory syndrome
(MIS-C) have been extensively described; however, our understanding of the longitudinal …

Importance Multiple inflammatory syndrome in children (MIS-C) occurs in association with
the COVID-19 pandemic. Objective To describe the clinical characteristics and geographic …